| Symbol | ROIV |
|---|---|
| Name | ROIVANT SCIENCES LTD. |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 11-12 ST. JAMESS SQUARE,SUITE 1, 3RD FLOOR, LONDON, SW1Y 4LB, United Kingdom |
| Telephone | +44 2074003347 |
| Fax | — |
| — | |
| Website | https://www.roivant.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001635088 |
| Description | Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Additional info from NASDAQ: |
Director Gline Matthew 🔴 sold 76.2K shares of Roivant Sciences Ltd. (ROIV) at $35.39 ($2.7M) Transaction Date: Jun 30, 2026 | Filing ID: 000079
Read moreDirector Fitzgerald Meghan 🟡 adjusted position in 10.0K shares (1 derivative) of Roivant Sciences Ltd. (ROIV) at $34.90 Transaction Date: Jun 30, 2026 | Filing ID: 000004
Read moreTorti Frank 🔴 sold 40.3K shares of Roivant Sciences Ltd. (ROIV) at $35.39 ($1.4M) Transaction Date: Jun 30, 2026 | Filing ID: 000077
Read moreDirector Sukhatme Mayukh 🔴 sold 46.9K shares of Roivant Sciences Ltd. (ROIV) at $35.39 ($1.7M) Transaction Date: Jun 30, 2026 | Filing ID: 000075
Read moreMANCHESTER KEITH S 🔴 sold 1.6M shares of Roivant Sciences Ltd. (ROIV) at $35.45 ($56.4M) Transaction Date: Jun 26, 2026 | Filing ID: 291172
Read moreGold Daniel Allen 🔴 sold 1.4M shares of Roivant Sciences Ltd. (ROIV) at $35.28 ($49.4M) Transaction Date: Jun 26, 2026 | Filing ID: 291163
Read moreQVT Financial LP 🔴 sold 1.4M shares of Roivant Sciences Ltd. (ROIV) at $35.28 ($49.4M) Transaction Date: Jun 26, 2026 | Filing ID: 291139
Read moreDirector Sukhatme Mayukh 🟡 adjusted position in 1.0M shares (2 derivative) of Roivant Sciences Ltd. (ROIV) at $34.13 ($41.8M) Transaction Date: Jun 25, 2026 | Filing ID: 000073
Read more📋 MELISSA EPPERLY (Director) plans to sell 18K shares of ROIVANT SCIENCES LTD (at $34.07 each, total $605K) Filed: Jun 29, 2026 | ID: 006594
Read moreVenker Eric 🟡 adjusted position in 200.0K shares (1 derivative) of Roivant Sciences Ltd. (ROIV) at $33.51 ($8.2M) Transaction Date: Jun 24, 2026 | Filing ID: 000071
Read more| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| RVT-101 | DRUG | Phase PHASE3 | Alzheimer's Disease | COMPLETED | NCT02585934 |
| RVT-101 70 mg | DRUG | Phase PHASE2 | Dementia With Lewy Bodies | TERMINATED | NCT02928445 |
| RVT-101 35 mg tablets | DRUG | Phase PHASE3 | Alzheimer's Disease | TERMINATED | NCT02586909 |
| RVT-101 35 mg | DRUG | Phase PHASE2 | Dementia With Lewy Bodies | TERMINATED | NCT02928445 |
| Placebo | DRUG | Phase PHASE2 | Lewy Body Dementia | COMPLETED | NCT02640729 |
| Nelotanserin | DRUG | Phase PHASE2 | Lewy Body Dementia | COMPLETED | NCT02640729 |